Description

Brain pathology markers including amyloid-beta plaque burden and neuroinflammatory markers in APP/PS1 mice are quantified, showing reductions following jatrorrhizine administration.

Figure 4

Chart

Source Paper

Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice.

Scientific reports (2019)

PMID: 31862965

DOI: 10.1038/s41598-019-56149-9

Cite This Figure

![Figure 4: Brain pathology markers including amyloid-beta plaque burden and neuroinflammatory markers in APP/PS1 mice are quantified, showing reductions following jatrorrhizine administration.]()

> Source: Sheng Wang et al. "Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Defic." *Scientific reports*, 2019. PMID: [31862965](https://pubmed.ncbi.nlm.nih.gov/31862965/)

<figure>
  <img src="" alt="Brain pathology markers including amyloid-beta plaque burden and neuroinflammatory markers in APP/PS1 mice are quantified, showing reductions following jatrorrhizine administration." />
  <figcaption>Figure 4. Brain pathology markers including amyloid-beta plaque burden and neuroinflammatory markers in APP/PS1 mice are quantified, showing reductions following jatrorrhizine administration.<br>  Source: Sheng Wang et al. "Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Defic." <em>Scientific reports</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31862965/">31862965</a></figcaption>
</figure>

Preuves associées

Berberine pour Gut Dysbiosis

Note D · 2 études